Beyond Air, Inc. (XAIR)
Trading
Quantity
Profitability
Ownership
Largest Insider Buys in Sector
XAIR Insider Trading Activity
XAIR Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $1,603,844 | 7 | 100 |
Sells | $0 | 0 | 0 |
Related Transactions
| Lisi Steven A. | CEO and Chairman of the Board | 3 | $801,642 | 0 | $0 | $801,642 |
| Carey Robert | director | 2 | $784,342 | 0 | $0 | $784,342 |
| Lucera Erick | director | 1 | $15,565 | 0 | $0 | $15,565 |
| Gaul Michael A. | Chief Operating Officer | 1 | $2,294 | 0 | $0 | $2,294 |
About Beyond Air, Inc.
Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous …
Insider Activity of Beyond Air, Inc.
Over the last 12 months, insiders at Beyond Air, Inc. have bought $1.6M and sold $0 worth of Beyond Air, Inc. stock.
On average, over the past 5 years, insiders at Beyond Air, Inc. have bought $2.47M and sold $1.13M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Lisi Steven A. (CEO and Chairman of the Board) — $801,642. Carey Robert (director) — $784,342. Lucera Erick (director) — $15,565.
The last purchase of 6,000 shares for transaction amount of $2,294 was made by Gaul Michael A. (Chief Operating Officer) on 2025‑02‑19.
List of Insider Buy and Sell Transactions, Beyond Air, Inc.
| 2025-02-19 | Gaul Michael A. | Chief Operating Officer | 6,000 0.0072% | $0.38 | $2,294 | -28.45% | ||
| 2024-09-26 | Lisi Steven A. | CEO and Chairman of the Board | 1.48M 4.2606% | $0.50 | $744,662 | +4.14% | ||
| 2024-09-26 | Carey Robert | director | 1.48M 4.2606% | $0.50 | $744,662 | +4.14% | ||
| 2024-08-15 | Lisi Steven A. | CEO and Chairman of the Board | 50,000 0.09% | $0.37 | $18,340 | +6.67% | ||
| 2024-08-14 | Carey Robert | director | 100,000 0.1947% | $0.40 | $39,680 | -0.03% | ||
| 2024-08-14 | Lisi Steven A. | CEO and Chairman of the Board | 100,000 0.1896% | $0.39 | $38,640 | -0.03% | ||
| 2024-08-14 | Lucera Erick | director | 39,266 0.0764% | $0.40 | $15,565 | -0.03% | ||
| 2023-12-28 | Sale | Avniel Amir | Chief Business Officer | 25,000 0.0789% | $2.06 | $51,451 | -69.51% | |
| 2023-12-27 | Sale | Myers Jeff Lynn | Chief Medical Officer | 3,423 0.0107% | $2.21 | $7,579 | -70.76% | |
| 2023-12-18 | Carey Robert | director | 1.2M 3.6746% | $1.64 | $1.96M | -34.34% | ||
| 2023-12-18 | Lisi Steven A. | CEO and Chairman of the Board | 77,775 0.2375% | $1.63 | $126,797 | -34.34% | ||
| 2023-11-16 | Gaul Michael A. | Chief Operating Officer | 10,000 0.0353% | $1.77 | $17,700 | -21.90% | ||
| 2023-08-28 | Carey Robert | director | 250,000 0.7698% | $2.69 | $673,750 | -42.75% | ||
| 2023-08-21 | Carey Robert | director | 75,050 0.236% | $2.76 | $207,453 | -42.75% | ||
| 2023-08-18 | Carey Robert | director | 13,614 0.0424% | $2.64 | $35,940 | -40.75% | ||
| 2023-06-30 | Gaul Michael A. | Chief Operating Officer | 5,000 0.0177% | $4.51 | $22,550 | -58.80% | ||
| 2023-03-31 | Forbes William P | director | 5,000 0.0165% | $6.67 | $33,350 | -64.00% | ||
| 2023-03-30 | Carey Robert | director | 10,000 0.0329% | $6.45 | $64,500 | -62.73% | ||
| 2023-03-29 | Carey Robert | director | 10,000 0.0328% | $6.30 | $63,000 | -61.62% | ||
| 2023-03-28 | Lee Yoori | director | 3,115 0.0105% | $6.34 | $19,749 | -60.48% |
Insider Historical Profitability
| Lisi Steven A. | CEO and Chairman of the Board | 3249411 3.6809% | $872,791.79 | 21 | 4 | +8.79% |
| Carey Robert | director | 1476626 1.6727% | $396,621.74 | 32 | 0 | <0.0001% |
| Gaul Michael A. | Chief Operating Officer | 94150 0.1067% | $25,288.69 | 6 | 0 | <0.0001% |
| Lucera Erick | director | 43608 0.0494% | $11,713.11 | 2 | 0 | <0.0001% |
| BENTSUR RON | director | 144736 0.164% | $38,876.09 | 1 | 26 | <0.0001% |
XAIR Institutional Investors: Active Positions
| Increased Positions | 19 | +32.2% | 11M | +75.85% |
| Decreased Positions | 23 | -38.98% | 6M | -39.74% |
| New Positions | 10 | New | 11M | New |
| Sold Out Positions | 10 | Sold Out | 509,065 | Sold Out |
| Total Postitions | 55 | -6.78% | 20M | +36.11% |
XAIR Ownership Change vs Market
Institutional Investor Ownership
| Alyeska Investment Group, L.P. | $1,928.00 | 8.12% | 7.14M | +7M | New | 2024-12-31 |
| Balyasny Asset Management L.P. | $900.00 | 3.79% | 3.33M | +3M | New | 2024-12-31 |
| Lasry Marc | $754.00 | 3.17% | 2.79M | -2M | -43.55% | 2024-12-31 |
| Vanguard Group Inc | $341.00 | 1.44% | 1.26M | 0 | 0% | 2024-12-31 |
| Soros Fund Management Llc | $270.00 | 1.14% | 1M | -476,626 | -32.28% | 2024-12-31 |
| Aigh Capital Management Llc | $268.00 | 1.13% | 991,476 | -3M | -72.48% | 2024-12-31 |
| Bleichroeder Lp | $199.00 | 0.84% | 738,313 | 0 | 0% | 2024-12-31 |
| Kingdon Capital Management, L.L.C. | $153.00 | 0.65% | 567,526 | 0 | 0% | 2024-12-31 |
| Geode Capital Management, Llc | $152.00 | 0.64% | 562,713 | +251,823 | +81% | 2024-12-31 |
| Blackrock, Inc. | $149.00 | 0.63% | 551,021 | +29,738 | +5.71% | 2024-12-31 |